Imaflex Inc
SymbolIFX.A
Shares Issued39,350,002
Close 2009-11-04C$ 0.31
Recent Sedar Documents

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

Imaflex loses $468,000 in third quarter

2009-11-13 05:38 ET - News Release

Mr. Joseph Abbandonato reports

IMAFLEX INC. ANNOUNCES RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2009

Imaflex Inc. has released results for the third quarter ended Sept. 30, 2009.

                           FINANCIAL RESULTS
              (in thousands, except per-share amounts)

                                  For the three months For the nine months
                                     ended Sept. 30,     ended Sept. 30,
                                     2009      2008      2009      2008

Sales                             $ 11,914  $ 13,976  $ 38,109  $ 40,104
Cost of sales                       10,304    12,306    31,604    34,643
Gross profit (before
amortization)                        1,610     1,670     6,505     5,461
Gross profit (%)(before
amortization)                         13.5%     11.9%     17.1%     13.6%
Amortization of production
equipment                              708       778     2,158     2,283
Gross profit                           902       892     4,347     3,178
Gross profit (%)                       7.6%      6.4%     11.4%      7.9%
Expenses                             1,231     1,388     3,254     4,036
FX loss (gain)                         255       207       502       344
Income (loss) before income taxes     (584)     (703)      591    (1,202)
Provision for income taxes            (116)     (117)      336       141
Net income (loss)                     (468)     (586)      255    (1,343)
Basic and diluted earnings per
share                               (0.012)   (0.016)    0.006    (0.036)
EBITDA                                 327       388     3,322     1,987

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.